Cell Death Discovery, 2025
Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells

Hajikhezri Z., Zygouras I., Sönnerborg A. et al.

Scientific Reports, 2025
Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy

Zhang R., Chang R., Wang H. et al.

Journal of Proteome Research, 2025
Serum Immune-Response Protein Biomarkers Based on Olink Technology for Diagnosis of Ischemic Stroke

Wang H., Zhao T., Zeng J. et al.

Journal of Ethnopharmacology, 2025
Lianhua Qingke Tablet in severe pneumonia: Clinical efficacy and immunoregulatory mechanisms

Jin P., Qi H., Zhao J. et al.

Journal of Translational Medicine, 2025
Multi-omics dissection of metabolic dysregulation associated with immune recovery in people living with HIV-1

Wan L., Lam S., Huang H. et al.

Clinical Cancer Research, 2025
Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma

Till J., Seewald N., Yazdani Z. et al.

Molecular Neurobiology, 2025
Prospective Investigation Unravels Plasma Proteomic Links to Dementia

Li J., Li J., Chen S. et al.

Rheumatology, 2025
Plasma proteomics for risk prediction and identification of novel drug targets in systemic lupus erythematosus

Yang S., Zhang Y., Ye Z. et al.

Nature Medicine, 2025
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection

Duff E., Zetterberg H., Heslegrave A. et al.

Frontiers in Oncology, 2025
Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Uffenorde J., Hariri M., Papalanis E. et al.

Science Translational Medicine, 2025
Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection

Chan L., Pinedo K., Stabile M. et al.

Nature Communications, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

Bolsewig K., Willemse E., Sánchez-Juan P. et al.

Journal of Inflammation Research, 2025
CLEC11A-Driven Molecular Mechanisms in Intervertebral Disc Degeneration: A Comprehensive Multi-Omics Study

Jiang N., Wang Q., Hu Z. et al.

Scientific Reports, 2025
Increased FGF-19 levels following explantation in women with breast implant illness

Azahaf S., Spit K., de Blok C. et al.

Heliyon, 2025
Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning

Safi A., Giunti E., Melikechi O. et al.

Atherosclerosis, 2025
Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization

Xu D., Lu J., Yang Y. et al.

Current Issues in Molecular Biology, 2025
The Role of Cytokines and Chemokines as Biomarkers of Disease Activity in Idiopathic Nephrotic Syndrome in Children

Kopač M., Jerin A., Petrera A. et al.

Frontiers in Immunology, 2025
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis

Ozuna H., Bojja D., Partida-Sanchez S. et al.

Journal for ImmunoTherapy of Cancer, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

Pakola S., Clubb J., Kudling T. et al.

Scientific Reports, 2025
Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics

Liu Y., Zhang Y., Wan Q.